Modelling the Anatomic Distribution of Neurologic Events in Patients with COVID-19: A Systematic Review of MRI Findings

References

1. 1.↵
   1. Grant MC,
   2. Geoghegan L,
   3. Arbyn M, et al

   . The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 2020;15:e0234765 doi:10.1371/journal.pone.0234765] pmid:32574165

   CrossRefPubMed
2. 2.↵
   1. Aghagoli G,
   2. Gallo Marin B,
   3. Katchur NJ, et al

   . Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care 2020 Jul 13. [Edpub ahead of print] doi:10.1007/s12028-020-01049-4 pmid:32661794

   CrossRefPubMed
3. 3.↵
   1. Ellul M,
   2. Benjamin L,
   3. Singh B, et al

   . Neurological associations of COVID-19. Lancet Neurol 2020;19:767–83 doi:10.1016/S1474-4422(20)30221-0 pmid:32622375

   CrossRefPubMed
4. 4.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–90 doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
5. 5.↵
   1. Varatharaj A,
   2. Thomas N,
   3. Ellul MA, et al

   . CoroNerve Study Group. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 2020;7:875–82 doi:10.1016/S2215-0366(20)30287-X pmid:32593341

   CrossRefPubMed
6. 6.↵
   1. Radmanesh A,
   2. Derman A,
   3. Lui YW, et al

   . COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020;297:E223–27 doi:10.1148/radiol.2020202040 pmid:32437314

   CrossRefPubMed
7. 7.↵
   1. Kremer S,
   2. Lersy F,
   3. de Seze J, et al

   . SFNR-COVID Group. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology 2020;297:E242–51 doi:10.1148/radiol.2020202222 pmid:32544034

   CrossRefPubMed
8. 8.↵
   WHO Coronavirus (COVID 19) Dashboard. Covid19.who.int.https://covid19.who.int/. Published 2020. Accessed October 15, 2020
9. 9.↵
   1. Katal S,
   2. Balakrishnan S,
   3. Gholamrezanezhad A

   . Neuroimaging findings in COVID-19 and other coronavirus infections: a systematic review in 116 patients. J Neuroradiol 2021;48:43–50 doi:10.1016/j.neurad.2020.06.007 pmid:32603770

   CrossRefPubMed
10. 10.↵
    1. Kremer S,
    2. Lersy F,
    3. Anheim M, et al

    . Neurologic and neuroimaging findings in COVID-19 patients: a retrospective multicenter study. Neurology 2020;95:e1868–82 doi:10.1212/WNL.0000000000010112 pmid:32680942

    CrossRefPubMed
11. 11.↵
    1. Hernandez-Fernandez F,
    2. Valencia HS,
    3. Barbella-Aponte RA, et al

    . Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain 2020;143:3089–3103 doi:10.1093/brain/awaa239 pmid:3264515

    CrossRefPubMed
12. 12.↵
    1. Politi LS,
    2. Salsano E,
    3. Grimaldi M

    . Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol 2020;77:1028–29 doi:10.1001/jamaneurol.2020.2125 pmid:32469400

    CrossRefPubMed
13. 13.↵
    1. Kandemirli SG,
    2. Dogan L,
    3. Sarikaya ZT, et al

    . Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 2020;297:E232–35 doi:10.1148/radiol.2020201697] pmid:32384020

    CrossRefPubMed
14. 14.↵
    1. Debette S,
    2. Markus H

    . The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666 doi:10.1136/bmj.c3666 pmid:20660506

    Abstract/FREE Full Text
15. 15.↵
    1. Wardlaw JM,
    2. Valdés Hernández MC,
    3. Muñoz ‐Maniega S

    . What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc 2015;4:e001140 doi:10.1161/JAHA.114.001140 pmid:6104658

    FREE Full Text
16. 16.↵
    1. Fitsiori A,
    2. Pugin D,
    3. Thieffry C, et al

    . Unusual microbleeds in brain MRI of Covid-19 patients. J Neuroimaging 2020;30:593–97 doi:10.1111/jon.12755

    CrossRef
17. 17.↵
    1. Cannac O,
    2. Martinez-Almoyna L,
    3. Hraiech S

    . Critical illness-associated cerebral microbleeds in COVID-19 acute respiratory distress syndrome. Neurology 2020;95:498–99 doi:10.1212/WNL.0000000000010537 pmid:32727834

    Abstract/FREE Full Text
18. 18.↵
    1. Scullen T,
    2. Keen J,
    3. Mathkour M, et al

    . Coronavirus 2019 (COVID-19)-associated encephalopathies and cerebrovascular disease: the New Orleans experience. World Neurosurg 2020;141:e437–46 doi:10.1016/j.wneu.2020.05.192 pmid:32474092

    CrossRefPubMed
19. 19.↵
    1. Poudel GR,
    2. Dominguez JF,
    3. Verhelst H, et al

    . Network diffusion modeling predicts neurodegeneration in traumatic brain injury. Ann Clin Transl Neurol 2020;7:270–79 doi:10.1002/acn3.50984 pmid:32105414

    CrossRefPubMed
20. 20.↵
    1. Poudel GR,
    2. Harding IH,
    3. Egan GF, et al

    . Network spread determines severity of degeneration and disconnection in Huntington’s disease. Hum Brain Mapp 2019;40:4192–4201 doi:10.1002/hbm.24695 pmid:31187915

    CrossRefPubMed
21. 21.↵
    1. Payus AO,
    2. Lin CL,
    3. Noh MM, et al

    . SARS-CoV-2 infection of the nervous system: a review of the literature on neurological involvement in novel coronavirus disease (COVID-19). Bosn J Basic Med Sci 2020;20:283–92 doi:10.17305/bjbms.2020.4860 pmid:32530389

    CrossRefPubMed
22. 22.↵
    1. DosSantos MF,
    2. Devalle S,
    3. Aran V, et al

    . Neuromechanisms of SARS-CoV-2: a review. Front Neuroanat 2020;14:37 doi:10.3389/fnana.2020.00037 pmid:32612515

    CrossRefPubMed
23. 23.↵
    1. Edlow BL,
    2. Takahashi E,
    3. Wu O, et al

    . Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders. J Neuropathol Exp Neurol 2012;71:531–46 doi:10.1097/NEN.0b013e3182588293 pmid:22592840

    CrossRefPubMed
24. 24.↵
    1. Afshar H,
    2. Yassin Z,
    3. Kalantari S, et al

    . Evolution and resolution of brain involvement associated with SARS- CoV2 infection: a close clinical-paraclinical follow up study of a case. Mult Scler Relat Disord 2020;43:102216 doi:10.1016/j.msard.2020.102216 pmid:32464585

    CrossRefPubMed
25. 25.↵
    1. Ding J,
    2. Sigurðsson S,
    3. Jónsson PV, et al

    . Space and location of cerebral microbleeds, cognitive decline, and dementia in the community. Neurology 2017;88:2089–97 doi:10.1212/WNL.0000000000003983 pmid:28468844

    Abstract/FREE Full Text
26. 26.↵
    1. Wang Y,
    2. Jiang Y,
    3. Suo C, et al

    . Deep/mixed cerebral microbleeds are associated with cognitive dysfunction through thalamocortical connectivity disruption: the Taizhou Imaging Study. Neuroimage Clin 2019;22:101749 doi:10.1016/j.nicl.2019.101749 pmid:30875641

    CrossRefPubMed
27. 27.↵
    1. Bonardel C,
    2. Bonnerot M,
    3. Ludwig M, et al

    . Bilateral posterior cerebral artery territory infarction in a SARS-Cov-2 infected patient: discussion about an unusual case. J Stroke Cerebrovasc Dis 2020;29:105095 doi:10.1016/j.jstrokecerebrovasdis.2020.105095 pmid:32807489

    CrossRefPubMed
28. 28.
    1. Guillan M,
    2. Villacieros-Alvarez J,
    3. Bellido S, et al

    . Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient. Thromb Res 2020;193:107–09 doi:10.1016/j.thromres.2020.06.015 pmid:32534327

    CrossRefPubMed
29. 29.↵
    1. Novi G,
    2. Rossi T,
    3. Pedemonte E, et al

    . Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 2020;77:e797 doi:10.1212/NXI.0000000000000797 pmid:32482781

    CrossRefPubMed
30. 30.↵
    1. Netland J,
    2. Meyerholz DK,
    3. Moore S, et al

    . Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82:7264–75 doi:10.1128/JVI.00737-08 pmid:18495771

    Abstract/FREE Full Text
31. 31.↵
    1. Desforges M,
    2. Le Coupanec A,
    3. Dubeau P, et al

    . Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2019;12:14 doi:10.3390/v12010014 pmid:31861926

    CrossRefPubMed
32. 32.↵
    1. Bailey DM,
    2. Bärtsch P,
    3. Knauth M, et al

    . Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological. Cell Mol Life Sci 2009;66:3583–94 doi:10.1007/s00018-009-0145-9 pmid:19763397

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Wang Y,
    2. Liu G,
    3. Hong D, et al

    . White matter injury in ischemic stroke. Prog Neurobiol 2016;141:45–60 doi:10.1016/j.pneurobio.2016.04.005 pmid:27090751

    CrossRefPubMed
34. 34.↵
    1. Martinez-Ramirez S,
    2. Greenberg SM,
    3. Viswanathan A

    . Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther 2014;6:33 doi:10.1186/alzrt263 pmid:24987468

    CrossRefPubMed
35. 35.↵
    1. Agarwal S,
    2. Jain R,
    3. Dogra S, et al

    . Cerebral microbleeds and leukoencephalopathy in critically ill patients with COVID-19. Stroke 2020;51:2649–55 doi:10.1161/STROKEAHA.120.030940 pmid:32755456

    CrossRefPubMed
36. 36.↵
    1. Lu Y,
    2. Li X,
    3. Geng D, et al

    . Cerebral micro-structural changes in COVID-19 patients: an MRI-based 3-month follow-up study. EClinicalMedicine 2020;25:100484 doi:10.1016/j.eclinm.2020.100484 pmid:32838240

    CrossRefPubMed